Full results from two Lilly trials of the novel triple hormone receptor agonist show reductions in A1c, osteoarthritis knee pain, and obstructive sleep apnea.

Patients with obesity and type 2 diabetes have more favorable QOL outcomes taking a GLP-1 than those with either condition alone or with multiple comorbidities.

Patients with RA have a higher risk of blood clots and serious infections with baricitinib vs older biologics, but not heart disease or cancer, according to two safety trials.

Cigarette smokers have a significantly lower likelihood of being diagnosed with Sjögren's disease, with histologic data showing less tissue damage and lower disease activity in smokers who have it.

A 14-month-old female with a history of atopy presented with an 8-month history of a persistent, non-tender, non-bleeding ...

More nurses regularly take on second shifts but as the practice becomes normalized, is this best for patients?

New research suggests that time and aging change how people deal with regrets. Here’s what it could mean for doctors.

Weekly subcutaneous injections of the novel B-cell inhibitor obexelimab significantly reduces disease flares and lowers toxic ...

For men with localized prostate cancer, proton therapy looks no better than IMRT when it comes to 3-year biochemical ...

Low-dose rivaroxaban failed to cut the high cardiovascular risk in this population in a large randomized trial, contrasting ...

Learning through art history that obesity once denoted prosperity, strength, and beauty, may help healthcare providers treat ...

A pilot study shows that a urine-based metabolite panel accurately distinguishes children with autism from typically ...